These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36563796)

  • 1. Mesoporous silica nanoparticles as carrier to overcome bacterial drug resistant barriers.
    Zhuang J; Yu Y; Lu R
    Int J Pharm; 2023 Jan; 631():122529. PubMed ID: 36563796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility.
    Gounani Z; Asadollahi MA; Pedersen JN; Lyngsø J; Skov Pedersen J; Arpanaei A; Meyer RL
    Colloids Surf B Biointerfaces; 2019 Mar; 175():498-508. PubMed ID: 30572158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant
    Memar MY; Yekani M; Ghanbari H; Shahi S; Sharifi S; Maleki Dizaj S
    Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1354-1361. PubMed ID: 33236938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility.
    Gounani Z; Asadollahi MA; Meyer RL; Arpanaei A
    Int J Pharm; 2018 Feb; 537(1-2):148-161. PubMed ID: 29278732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of chiral D-cysteine by pH-responsive mesoporous silica nanoparticles for effective bacterial inhibition.
    Ye Z; Qian J; Zhang J; Yan W
    J Microbiol Methods; 2023 Aug; 211():106776. PubMed ID: 37385455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers.
    Wang Y; Gou K; Guo X; Ke J; Li S; Li H
    Acta Biomater; 2021 Mar; 123():72-92. PubMed ID: 33454385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo.
    Li LL; Wang H
    Adv Healthc Mater; 2013 Oct; 2(10):1351-60. PubMed ID: 23526816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of mesoporous silica/hydroxyapatite loaded quercetin nanoparticles and research on its antibacterial properties.
    Yi X; Bao F; Fu S; Yang Y; Xu Y
    Med Eng Phys; 2024 Apr; 126():104160. PubMed ID: 38621842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting antibacterial activity with mesoporous silica nanoparticles supported silver nanoclusters.
    Liu J; Li S; Fang Y; Zhu Z
    J Colloid Interface Sci; 2019 Nov; 555():470-479. PubMed ID: 31400539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powering mesoporous silica nanoparticles into bioactive nanoplatforms for antibacterial therapies: strategies and challenges.
    Li B; Liao Y; Su X; Chen S; Wang X; Shen B; Song H; Yue P
    J Nanobiotechnology; 2023 Sep; 21(1):325. PubMed ID: 37684605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.
    Tian Y; Qi J; Zhang W; Cai Q; Jiang X
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):12038-45. PubMed ID: 25050635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
    Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
    Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Inhibition of Drug-Resistant
    Ye Z; Wang S; Xu Y; Zhang J; Yan W
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
    Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
    Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
    González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Layer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications.
    Wu Y; Long Y; Li QL; Han S; Ma J; Yang YW; Gao H
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17255-63. PubMed ID: 26192024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous Silica-Based Materials with Bactericidal Properties.
    Bernardos A; Piacenza E; Sancenón F; Hamidi M; Maleki A; Turner RJ; Martínez-Máñez R
    Small; 2019 Jun; 15(24):e1900669. PubMed ID: 31033214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.